Corifollitropin alfa for poor responders patients, a prospective randomized study

Abstract Background Poor ovarian response remains one of the biggest challenges for reproductive endocrinologists. The introduction of corifollitropin alpha (CFA) offered an alternative option to other gonadotropins for its longer half-life, its more rapid achievement of the threshold and higher FSH...

Full description

Saved in:
Bibliographic Details
Main Authors: F. M. Fusi (Author), L. Zanga (Author), M. Arnoldi (Author), S. Melis (Author), M. Cappato (Author), I. Candeloro (Author), A. Di Pasqua (Author)
Format: Book
Published: BMC, 2020-07-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available